Accessibility Page Navigation
Style sheets must be enabled to view this page as it was intended.
The Royal College of Psychiatrists Improving the lives of people with mental illness

Evidence-Based Mental Health current issue

01/05/2016


Which role for brexpiprazole, a new dopamine D2 partial agonist, in the treatment of schizophrenia?

Citrome, L. Evidence-Based Mental Health, 19, e6 - e6.

Some augmentation strategies improve outcome but increase discontinuation in adults with treatment-resistant depression

Andrade, C. Evidence-Based Mental Health, 19, e7 - e7.

Long-acting injectable risperidone as an option in first-episode psychosis

Covell, N. H. Evidence-Based Mental Health, 19, e8 - e8.

Clonidine: new use of an old medication to reduce stress-related substance use

Woody, G. Evidence-Based Mental Health, 19, e9 - e9.

mHealth in psychiatry: time for methodological change

Nicholas, J., Boydell, K., Christensen, H. Evidence-Based Mental Health, 19, 33 - 34.

Ketamine for treatment-resistant depression: recent developments and clinical applications

Schwartz, J., Murrough, J. W., Iosifescu, D. V. Evidence-Based Mental Health, 19, 35 - 38.

Are all psychotherapies equally effective in the treatment of adult depression? The lack of statistical power of comparative outcome studies

Cuijpers, P. Evidence-Based Mental Health, 19, 39 - 42.

Computerised cognitive behaviour therapy for major depression: a reply to the REEACT trial

Andrews, G., Hobbs, M. J., Newby, J. M. Evidence-Based Mental Health, 19, 43 - 45.

Diagnosing autism spectrum disorder (ASD) among adults

Furukawa, T. A. Evidence-Based Mental Health, 19, 46 - 48.

Economic evaluation of mental health interventions: an introduction to cost-utility analysis

Luyten, J., Naci, H., Knapp, M. Evidence-Based Mental Health, 19, 49 - 53.

High-potency cannabis increases the risk of psychosis

Barkus, E. Evidence-Based Mental Health, 19, 54 - 54.

Impact of additive alcohol and substance use disorders on the mortality of people with schizophrenia and mood disorders

Chang, C.-K. Evidence-Based Mental Health, 19, 55 - 55.

Support for the link between adolescent mental health problems and subsequent perinatal depression: a 20-year prospective cohort study

Nilsen, W. Evidence-Based Mental Health, 19, 56 - 56.

Treatment of maternal perinatal depression in a low-income setting does not lead to improved outcomes for children

Ramchandani, P. G., King, D. X. Evidence-Based Mental Health, 19, 57 - 57.

Psychotic disorders cause the greatest mortality disparity among mental disorders, though more deaths are attributable overall to mood and anxiety disorders

Bradford, D. W., Cunningham, N. Evidence-Based Mental Health, 19, 58 - 58.

A negative randomised sham-controlled trial of ventral capsule/ventral striatum stimulation in treatment-resistant depression: an unsuccessful trial or treatment?

Ramasubbu, R. Evidence-Based Mental Health, 19, 59 - 59.

Alpha-7 nicotinic agonist improves cognition in schizophrenia

Marder, S. R. Evidence-Based Mental Health, 19, 60 - 60.

Lack of improvement at week 2 predicts later antipsychotic non-response in people with acute exacerbations of schizophrenia or schizophrenia-like psychosis

Kishi, T. Evidence-Based Mental Health, 19, 61 - 61.

Unnecessary psychotropic drug prescription in primary care for people with intellectual disability

Trollor, J., Salomon, C. Evidence-Based Mental Health, 19, 62 - 62.

Psychodynamic therapy: a poorly defined concept with questionable evidence

Hofmann, S. G. Evidence-Based Mental Health, 19, 63 - 63.

Psychodynamic therapy: a well-defined concept with increasing evidence

Leichsenring, F., Abbass, A., Gottdiener, W., Hilsenroth, M., Keefe, J. R., Luyten, P., Rabung, S., Steinert, C. Evidence-Based Mental Health, 19, 64 - 64.